# reload+after+2024-01-22 10:32:07.122305
longBusinessSummary§The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
maxAge§86400
priceHint§2
yield§0.0002
totalAssets§261493360
navPrice§65.07
currency§USD
category§Health
ytdReturn§-0.011127
beta3Year§0.8
fundFamily§Invesco
fundInceptionDate§1119484800
legalType§Exchange Traded Fund
threeYearAverageReturn§-0.0275949
fiveYearAverageReturn§0.059465397
exchange§PCX
quoteType§ETF
shortName§Invesco Biotechnology & Genome 
longName§Invesco Biotechnology & Genome ETF
firstTradeDateEpochUtc§1119533400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§eff7c557-1b26-3c9c-b48a-2c16d82e99f4
gmtOffSetMilliseconds§-18000000
trailingPegRatio§None
